Abstract
Overview
Introduction
The Critical Care Community is currently at its most organized, and motivated,
and on a mission to improve outcomes in sepsis. This is driving a rigorous
assessment of care strategies which is gathering speed and showing results.
This will yield many opportunities for developing products, but current
interventions' roles will change, with impacts on how they are measured, used
and valued.
Scope
- Insight into clinical and commercial developments tackling predisposition,
infection, response and organ dysfunction
- A translation of the complex, multifaceted processes involved in sepsis
into commercial realities for industry
- Perspectives from Contract Research, Biotech, Pharmaceutical and
Diagnostics sectors and leading figures from the sepsis and critical care
community
- Assessment of the impact of the Surviving Sepsis Campaign and the changes
in its latest set of guidelines on prescribing physicians
Highlights
The critical care community' s rigorous assessment of current management
strategies is now gathering speed and showing results, gaining more converts
and highlighting new perspectives on sepsis-related processes
Current interventions used in sepsis are typically either repurposed from
other disease areas, or based on nascent understandings of the processes in
play
Whilst this improved understanding may yield many new opportunities for
developing new interventions, the understanding of the roles of current
interventions may be turned upside-down, with implications for how they are
measured, used, and indeed, valued in improving outcomes
Reasons to Purchase
- Understand the clinical and commercial characteristics and priorities for
an increasingly complex therapy area
- Identify the elements of strategies that will either kept players at the
top of their field or fail completely
- Understand how these businesses and strategies relate to your interest in
the market, and how to position your products and services accordingly
View Cart
